{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:41:19Z","timestamp":1780929679754,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HD098312"],"award-info":[{"award-number":["K23HD098312"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.msard.2022.103508","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T08:19:09Z","timestamp":1641802749000},"page":"103508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Hypogonadism in men with multiple sclerosis: Prevalence and clinical associations"],"prefix":"10.1016","volume":"59","author":[{"given":"Claudiu","family":"Diaconu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaho","family":"Onomichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"De Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libby","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Shelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"De Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Straus","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.103508_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2013.03.005","article-title":"Sexual disparities in the incidence and course of MS","author":"Bove","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.msard.2022.103508_bib0002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imm.13004","article-title":"Impact of sex hormones on immune function and multiple sclerosis development","volume":"156","author":"Ysraelit","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.msard.2022.103508_bib0003","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1742-2094-5-32","article-title":"Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone","volume":"5","author":"Gold","year":"2008","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.msard.2022.103508_bib0004","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1177\/1352458514527864","article-title":"Low Testosterone is associated with disability in men with multiple sclerosis","volume":"20","author":"Bove","year":"2014","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2022.103508_bib0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jnnp.2003.033324","article-title":"Sex hormones modulate brain damage in multiple sclerosis: MRI evidence","volume":"76","author":"Tomassini","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.103508_bib0006","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3389\/fneur.2020.00756","article-title":"Gonadal steroids and sperm quality in a cohort of relapsing remitting multiple sclerosis: a case-control study","volume":"11","author":"D'Amico","year":"2020","journal-title":"Front. Neurol."},{"issue":"14","key":"10.1016\/j.msard.2022.103508_bib0007","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1177\/13524585211009208","article-title":"Male fertility in relapsing-remitting multiple sclerosis patients treated with natalizumab and ocrelizumab: a prospective case-control study","volume":"27","author":"D'Amico","year":"2021","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2022.103508_bib0008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ijir.2009.35","article-title":"The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism","volume":"22","author":"Mohamed","year":"2010","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.msard.2022.103508_bib0009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.metabol.2012.08.012","article-title":"The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review","volume":"62","author":"Michalakis","year":"2013","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.msard.2022.103508_bib0010","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.eururo.2007.05.021","article-title":"Relationship between the Saint Louis University ADAM questionnaire and sexual hormonal levels in a male outpatient population over 50 years of age","volume":"52","author":"Mart\u00ednez-Jabaloyas","year":"2007","journal-title":"Eur. Urol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:03:02Z","timestamp":1761901382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":10,"alternative-id":["S2211034822000232"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103508","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypogonadism in men with multiple sclerosis: Prevalence and clinical associations","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103508"}}